Pharmacodynamic Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, from a Randomized Study in Patients with Type 2 Diabetes
Abstract
- Publication:
-
PLoS ONE
- Pub Date:
- August 2014
- DOI:
- 10.1371/journal.pone.0105638
- Bibcode:
- 2014PLoSO...9j5638S